Business Combinations (Tables)

12 Months Ended

Sep. 30, 2023

Business Combinations [Abstract]

Schedule of assets acquired and liabilities assumed as of the acquisition date

The purchase price was allocated to B Medical’s tangible and identifiable intangible assets acquired and liabilities assumed based on the estimated fair values as of October 3, 2022, as set forth below (in thousands):

	Fair Value
Accounts receivable	$	19,549
Inventory		51,978
Other assets		10,769
Property plant and equipment		54,149
Identifiable Intangible Assets:
Completed technology		100,600
Trademarks		5,500
Customer relationships		36,700
Backlog		600
Other liabilities		(32,533)
Deferred income taxes, net		(43,393)
Goodwill		228,241
Total purchase price, net of cash acquired	$	432,160

Schedule of consolidated results

The following financial information reflects our consolidated results from B Medical (in thousands):

	Year Ended September 30,
	2023
Revenue	$	113,122
Net loss	$	(26,463)

Schedule of pro forma information

The following unaudited pro forma financial information reflects our consolidated results of operations as if the acquisition had taken place on October 1, 2021 (in thousands). The unaudited pro forma financial information is not necessarily indicative of the results of operations that we would have reported had the transaction occurred at the beginning of these periods nor is it necessarily indicative of future results.

	Year Ended September 30,
	2023		2022
Revenue	$	665,072	$	672,151
Net income (loss)	$	(5,356)	$	2,111,185